In order to determine the significance of TP53 germline mutations to breast cancer risk in our multi-ethnic cohort, we sought to determine the prevalence of TP53 germline mutations in a hospital-based cohort of Asian breast cancer patients diagnosed before age 35 years. Here, TP53 is linked to breast carcinoma.